EFFECT OF NARINGENIN ON LIPIDS, LIPOPROTEINS AND LIPID METABOLISING ENZYMES IN 7,12-DIMETHYL BENZ(A)ANTHRACENE-INDUCED MAMMARY CARCINOGENESIS IN SD RATS
Objective: Mammary carcinoma is one of the most common and prominent cause of cancer-related death in women worldwide. The role of fatty acid synthesis and altered lipid metabolism in cancer progression was well established. Cancer cells undergo enhanced de-novo lipogenesis and liver uptake. The magnitudes of bioflavonoids in lipid management against various cancers have been established. In the present study, we evaluated the efficacy of a bioflavonoid Naringenin (NGN) to re-establish the lipid metabolic alterations in 7, 12-dimethyl benz (a) anthracene (DMBA)-induced mammary carcinoma in Sprague Dawley (SD) rats.
Methods: DMBA-induced mammary carcinoma was developed using air pouch technique (20 mg in 0.5 ml olive oil) following a 118 d experimental protocol. NGN (40, 80 mg/kg b. w.; i. p.) was given for 28 d after promotional stage (90 d) of carcinoma bearing animals. The changes in body weight (b. w.), lipids, lipoproteins and lipid metabolising enzymes (LME) level were estimated and correlated with anticancer potentials of NGN.
Results: The results indicated a dose dependant significant (p<0.05) restorative effect of NGN on body weight of cancer-bearing animals. The changes in lipid level in plasma and liver tissue were re-established after treatment. Lipoproteins and LME were also changed in cancer-bearing animals with that of NGN treatment significantly (p<0.01).
Conclusion: NGN potentially reverted the changes in body weight, lipid profile, LME that config. its anticancer potential against mammary carcinogenesis.
2. American Cancer Society. Cancer Treatment and Survivorship Facts and fig. 2014-2015. Atlanta: American Cancer Society; 2014.
3. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 2005;165:2264â€“71.
4. Kitahara CM, Berrington De Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 2011;29:1592â€“8.
5. Kaye JA, Meier CR, Walker AM, Jick H. Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer 2002;86:1436â€“9.
6. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 1953;13:27â€“9.
7. Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000;88:176â€“9.
8. Yoon S, Lee MY, Park SW, Moon JS, Koh YK, Ahn YH, et al. Up-regulation of acetyl-CoA carboxylase and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem 2007;282:26122â€“31.
9. Santos CR, Schulze A. Lipid metabolism in cancer. FERB J 2012;279:2610-23.
10. Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Models Mech 2013;6:1353-63.
11. Hager MH, Solomon KR, Freeman MR. The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care 2006;9:379â€“85.
12. Clayman RV, Gonzalez R, Elliott AY, Gleason DE, Dempsey ME. Cholesterol accumulation in hetero transplanted renal cell cancer. J Urol 1983;129:621â€“4.
13. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010;11:688-99.
14. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010;70:8117-26.
15. Ke JY, Kliewer KL, Hamad EM, Cole RM, Kimberly AP, Andridge RR, et al. The flavonoids, NGN, decrease adiose tissue mass and attenuates ovariectomy-associated metabolic distribution in mice. Nut Metab 2015;12:1-10.
16. Bok SH, Shin YW, Bae KH, Jeong TS, Kwon YK, Park YB, et al. Effects of naringin and lovastatin on plasma and hepatic lipids in high-fat and high cholesterol fed rats. Nutr Res 2000;20:1007â€“15.
17. Arun B, Udayachander M, Meenakshi A. 7,12-dimethyl benz(a)anthracene induced mammary tumour in Wistar rats by â€œAir pouch techniqueâ€-a new approach. Cancer Lett 1984;25:187-94.
18. Pattanayak SP, Sunita P, Mazumder PM. Restorative effect of Dendrophthoe falcata (L. f.) Ettingsh on lipids, lipoproteins, and lipid-metabolizing enzymes in DMBA-induced mammary gland carcinogenesis in Wistar female rats. Comp Clin Pathol 2014;23:1013-22.
19. Folch J, Less M, Stanely GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1951;226:504â€“9.
20. Van Handle E. Modification of the micro determination of triglycerides. Clin Chem 1961;7:249â€“51.
21. Rice EW. Triglycerides in serum. In: Roderick P, Mac-Donald CH. editors. Standard methods of clinical chemistry, 6th edn. New York: Academic Press; 1970. p. 215â€“22.
22. Rouser G, Fleisher S, Yamanoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970;5:494â€“6.
23. Parkeh AC, Jung DH. Cholesterol determination with ferric chloride uranium acetate and sulphuric acidâ€“ferrous sulphate reagents. Anal Chem 1970;42:1423â€“7.
24. Leffler HH, McDougald CH. A colorimetric method for the estimation of cholesterol. Am J Clin Pathol 1963;39:311â€“3.
25. Horn WT, Menahan LA. A sensitive method for the determination of free fatty acids in plasma. J Lipid Res 1981;22:377â€“81.
26. Sujatha V, Sachdanandam P. Effect of Semicarpus anacardium Linn nut extract on experimental mammary carcinoma in Spague-Dawley rats with reference to tumor marker enzymes. Pharm Pharmacol Commun 1997;6:375â€“9.
27. Schmidt A. Measurement of lipoprotein lipase and hepatic triglyceride lipase in human post heparin plasma. Methods Enzymol 1974;72:325â€“37.
28. Bier M. Enzymes of lipid metabolism, lipases and esterases. Methods Enzymol 1955;1:631â€“8.
29. Kothari HV, Bonner MJ, Miller BF. Cholesterol ester hydrolase in homogenates and lysosomal fractions of human aorta. Biochem Biophys Acta 1970;202:325â€“31.
30. Legraud A, Guillansseav RJ, Land J. Method colorimetric simple determination delâ€™activit, de la lecithin cholesterol acyl transferase (LCAT) Plasmatique, interest on diabeteologic. In: Siest G, Glateau MM. editors. Biologic prospective. Paris: Masson; 1979. p. 368â€“71.
31. Hitz J, Sternmetz J, Siest G. Plasma LCAT reference values and effects of xenobiotics. Clin Chim Acta 1983;133:85â€“96.
32. Bloch AS. editor. Nutrition Management of the Cancer Patient. New York: ASPEN; 1990.
33. Antalis CJ, Uchida A, Buhman KK, Siddiqui RA. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Clin Exp Metastasis 2011;28:733â€“41.
34. Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res Treat 2010;122:661â€“70.
35. Rotheneder M, Kostner GM. Effects of low and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines. Int J Cancer 1989;43:875â€“9.
36. Damen J, Ramshorst JV, Hoeven RPV. Alterations in plasma lipoproteins and heparin-releasable lipase activities in mice bearing the GRSl ascites tumour. Biochem Biophys Acta 1984;793:287-96.
37. Dessi S, Batetta B, Anchisi C, Pani P, Costelli P, Tessitore L, et al. Cholesterol metabolism during the groeth of a rat ascites hepatoma (Yoshida AH-130). Breast Cancer J 1992;66:187-93.
38. Basu TK, Williams DC. Plasma and body lipids in patient with carcinoma in the breast. Oncol 2005;31:172-6.